Found: 27
Select item for more details and to access through your institution.
Genomic Diversity, Antimicrobial Resistance, Plasmidome, and Virulence Profiles of Salmonella Isolated from Small Specialty Crop Farms Revealed by Whole-Genome Sequencing.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 11, p. 1637, doi. 10.3390/antibiotics12111637
- By:
- Publication type:
- Article
Prevalence and Antimicrobial Resistance Profiles of Foodborne Pathogens Isolated from Dairy Cattle and Poultry Manure Amended Farms in Northeastern Ohio, the United States.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 12, p. 1450, doi. 10.3390/antibiotics10121450
- By:
- Publication type:
- Article
Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines.
- Published in:
- BMC Veterinary Research, 2014, v. 10, n. 1, p. 160, doi. 10.1186/1746-6148-10-160
- By:
- Publication type:
- Article
Selinexor‐based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. e126, doi. 10.1111/bjh.16550
- By:
- Publication type:
- Article
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition.
- Published in:
- Scientific Reports, 2015, p. 16077, doi. 10.1038/srep16077
- By:
- Publication type:
- Article
Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137210
- By:
- Publication type:
- Article
Specific Inhibition of the Nuclear Exporter Exportin-1 Attenuates Kidney Cancer Growth.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0113867
- By:
- Publication type:
- Article
Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0102983
- By:
- Publication type:
- Article
Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087585
- By:
- Publication type:
- Article
Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
A longitudinal study to examine the influence of farming practices and environmental factors on pathogen prevalence using structural equation modeling.
- Published in:
- Frontiers in Microbiology, 2023, v. 14, p. 1, doi. 10.3389/fmicb.2023.1141043
- By:
- Publication type:
- Article
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Promising SINEs in the Treatment of Pancreatic Cancer.
- Published in:
- JOP Journal of the Pancreas, 2015, v. 16, n. 4, p. 342
- By:
- Publication type:
- Article
Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e115, doi. 10.1016/j.clml.2019.09.191
- By:
- Publication type:
- Article
Oral Selinexor Shows Single Agent Activity Enhanced With PI or IMID Combinations in Refractory Multiple Myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e13, doi. 10.1016/j.clml.2017.03.023
- By:
- Publication type:
- Article
KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 487, doi. 10.1007/s00280-014-2495-8
- By:
- Publication type:
- Article
Tolerability, Pharmacokinetics, and Neuroendocrine Effects of PRX-00023, a Novel 5-HT1A Agonist, in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2007, v. 47, n. 7, p. 817, doi. 10.1177/0091270007300953
- By:
- Publication type:
- Article
XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor Cells.
- Published in:
- Journal of Cellular Physiology, 2016, v. 231, n. 12, p. 2711, doi. 10.1002/jcp.25378
- By:
- Publication type:
- Article
Cover Image, Volume 231, Number 12, December 2016.
- Published in:
- 2016
- By:
- Publication type:
- Other
Overall survival of patients with triple‐class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E5, doi. 10.1002/ajh.26010
- By:
- Publication type:
- Article
Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0304-z
- By:
- Publication type:
- Article
XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 46, doi. 10.1186/1756-8722-7-46
- By:
- Publication type:
- Article
KPT-330 inhibitor of CRM1 ( XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 1, p. 117, doi. 10.1111/bjh.12231
- By:
- Publication type:
- Article
Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01319-y
- By:
- Publication type:
- Article
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models.
- Published in:
- BMC Cancer, 2015, v. 15, p. 941, doi. 10.1186/s12885-015-1936-z
- By:
- Publication type:
- Article
Induction of p53-mediated transcription and apoptosis by exportin-1 ( XPO1) inhibition in mantle cell lymphoma.
- Published in:
- Cancer Science, 2014, v. 105, n. 7, p. 795, doi. 10.1111/cas.12430
- By:
- Publication type:
- Article
Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma.
- Published in:
- EJHaem, 2021, v. 2, n. 1, p. 48, doi. 10.1002/jha2.120
- By:
- Publication type:
- Article